- Home
- SIDU vs PULM Comparison
SIDU vs PULM Comparison
Compare SIDU & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- PULM
- Stock Information
- Founded
- SIDU 2012
- PULM 2003
- Country
- SIDU United States
- PULM United States
- Employees
- SIDU N/A
- PULM N/A
- Industry
- SIDU Telecommunications Equipment
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- PULM Health Care
- Exchange
- SIDU Nasdaq
- PULM Nasdaq
- Market Cap
- SIDU 30.0M
- PULM 33.2M
- IPO Year
- SIDU 2021
- PULM N/A
- Fundamental
- Price
- SIDU $1.73
- PULM $6.94
- Analyst Decision
- SIDU
- PULM
- Analyst Count
- SIDU 0
- PULM 0
- Target Price
- SIDU N/A
- PULM N/A
- AVG Volume (30 Days)
- SIDU 702.0K
- PULM 62.8K
- Earning Date
- SIDU 08-18-2025
- PULM 08-12-2025
- Dividend Yield
- SIDU N/A
- PULM N/A
- EPS Growth
- SIDU N/A
- PULM N/A
- EPS
- SIDU N/A
- PULM N/A
- Revenue
- SIDU $3,860,985.00
- PULM $1,921,000.00
- Revenue This Year
- SIDU $144.49
- PULM N/A
- Revenue Next Year
- SIDU N/A
- PULM $134.88
- P/E Ratio
- SIDU N/A
- PULM N/A
- Revenue Growth
- SIDU N/A
- PULM N/A
- 52 Week Low
- SIDU $1.14
- PULM $1.78
- 52 Week High
- SIDU $7.65
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- SIDU 58.29
- PULM 42.62
- Support Level
- SIDU $1.49
- PULM $6.36
- Resistance Level
- SIDU $1.82
- PULM $7.99
- Average True Range (ATR)
- SIDU 0.13
- PULM 0.90
- MACD
- SIDU 0.02
- PULM -0.24
- Stochastic Oscillator
- SIDU 72.73
- PULM 50.16
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).